Combined Post- and Precapillary Pulmonary Hypertension in Patients With Advanced Heart Failure
Circulation: Heart Failure · 18.08.2026
DOI: 10.1161/circheartfailure.126.014787 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Circulation: Heart Failure, online erschienen am 18.08.2026. Verfasst von E Ashley Hardin und 7 weiteren Autor:innen. Beteiligte Einrichtung: UT Southwestern Medical Center, Dallas, TX (E.A.H., A.D., P.D., N.H., M.H.D., K.M.C.). Die Arbeit nennt 100 Literaturangaben.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Pulmonary hypertension associated with left heart disease, or group 2 pulmonary hypertension, is common in patients with advanced heart failure. In at least a third of these patients, the pulmonary pressures are disproportionately elevated relative to left heart filling pressures and are classified as combined post- and precapillary pulmonary hypertension (CpcPH). CpcPH is thought to result not only from chronically elevated left heart filling pressures but also from neurohormonal activation, a genetic predisposition, and other risk factors. Traditional pulmonary vasodilator therapies are not efficacious and may be harmful in CpcPH. For patients with advanced heart failure, higher-risk CpcPH hemodynamics, particularly significantly elevated or nonreversible pulmonary vascular resistance and transpulmonary gradient, may preclude isolated heart transplantation, while acute vasodilator testing may identify patients who can proceed with acceptable risk. Strategies to minimize posttransplant risk in recipients with CpcPH based on donor selection, for example, oversizing of the donor by relative predicted heart mass or selecting donors with preexisting PH, remain unproven. This review serves to (1) highlight new insights into the pathophysiology and epidemiology of CpcPH; (2) summarize the existing literature surrounding indications for, and interpretation of response to, acute pulmonary vasodilator testing; (3) provide recommendations for management of patients with heart failure and CpcPH, with a particular focus on advanced therapies; and (4) identify knowledge gaps and future research priorities.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- UT Southwestern Medical Center, Dallas, TX (E.A.H., A.D., P.D., N.H., M.H.D., K.M.C.).
- Medical University of South Carolina, Charleston (R.J.T.).
- University of California San Francisco (T.D.M.).
ORCID-Profile: E Ashley Hardin, Adi Dewanjee, Parker Davis, Ryan J Tedford, Nick Hendren, Mark H Drazner, Teresa De Marco, Kelly M Chin
Zitieren
APA
Hardin, E. A., Dewanjee, A., Davis, P., Tedford, R. J., Hendren, N., Drazner, M. H., De Marco, T., & Chin, K. M. (2026). Combined Post- and Precapillary Pulmonary Hypertension in Patients With Advanced Heart Failure. Circulation: Heart Failure. https://doi.org/10.1161/circheartfailure.126.014787
Vancouver
Hardin EA, Dewanjee A, Davis P, Tedford RJ, Hendren N, Drazner MH, et al. Combined Post- and Precapillary Pulmonary Hypertension in Patients With Advanced Heart Failure. Circulation: Heart Failure. 2026. doi:10.1161/circheartfailure.126.014787
BibTeX
@article{Hardin2026,
author = {Hardin, E Ashley and Dewanjee, Adi and Davis, Parker and Tedford, Ryan J and Hendren, Nick and Drazner, Mark H and De Marco, Teresa and Chin, Kelly M},
title = {Combined Post- and Precapillary Pulmonary Hypertension in Patients With Advanced Heart Failure},
journal = {Circulation: Heart Failure},
year = {2026},
doi = {10.1161/circheartfailure.126.014787}
}
EUVIMED